Tenofovir Disoproxil Fumarate Lamivudine and Efavirenz Tablets

Product Description

The combination of Tenofovir Disoproxil Fumarate (300 mg), Lamivudine (300 mg), and Efavirenz (600 mg) is a common antiretroviral medication used in the treatment of HIV (human immunodeficiency virus) infection. This combination is often prescribed as a fixed-dose tablet and is known by various brand names.

Here's some information about each component:

1. Tenofovir Disoproxil Fumarate (TDF): Tenofovir is a nucleotide reverse transcriptase inhibitor (NRTI) that inhibits the activity of the reverse transcriptase enzyme, crucial for the replication of HIV. It is a prodrug, and once inside the body, it is converted to its active form, tenofovir diphosphate.

2. Lamivudine (3TC): Lamivudine is another nucleoside reverse transcriptase inhibitor (NRTI) that works similarly to Tenofovir. It also inhibits the reverse transcriptase enzyme, preventing the replication of the virus.

3. Efavirenz (EFV): Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by binding to and inhibiting the reverse transcriptase enzyme, disrupting the ability of the virus to replicate.

Key points about the combination:

• Indications: This combination is indicated for the treatment of HIV-1 infection in adults and pediatric patients who weigh at least 40 kg.

• Dosage: The usual dose is one tablet taken orally once daily, typically at bedtime.

• Adherence: Adherence to the prescribed regimen is crucial for the effectiveness of HIV treatment. It's important to take the medication consistently and as directed by a healthcare professional.

• Side Effects: Like any antiretroviral therapy, this combination can have side effects. Common side effects may include dizziness, drowsiness, nausea, and rash. It's essential to report any severe or persistent side effects to a healthcare provider.

• Pregnancy: This combination may be used during pregnancy, but the potential risks and benefits should be discussed with a healthcare provider.

As with any medication, it's important to follow the advice of your healthcare provider and pharmacist. They can provide information on potential interactions with other medications, monitor for side effects, and ensure the treatment plan is tailored to your specific health needs

Convenient Fixed-Dose Antiretroviral Therapy

The combination of Tenofovir Disoproxil Fumarate, Lamivudine, and Efavirenz enables patients to take all necessary medications for HIV-1 management in just one tablet daily. This streamlines treatment regimens, helps ensure adherence, and supports effective viral suppression. The tablets are designed for adults and adolescents weighing 35 kg or more, reducing pill burden and simplifying daily routines.


Quality and Safety Standards

This product meets international quality benchmarks, being WHO prequalified and approved by regulatory authorities. Manufactured and distributed in India, it comes in secure blister packaging marked with batch numbers and identification codes for traceability. It is prescription-only, ensuring professional medical oversight and individual suitability assessment before initiating therapy.